<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">avk</journal-id><journal-title-group><journal-title xml:lang="ru">Архивъ внутренней медицины</journal-title><trans-title-group xml:lang="en"><trans-title>The Russian Archives of Internal Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-6704</issn><issn pub-type="epub">2411-6564</issn><publisher><publisher-name>“SINAPS” LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20514/2226-6704-2025-15-3-187-198</article-id><article-id custom-type="edn" pub-id-type="custom">GEREGM</article-id><article-id custom-type="elpub" pub-id-type="custom">avk-2004</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group></article-categories><title-group><article-title>Содержание молекул межклеточной адгезии у пациентов с COVID-19-ассоциированным поражением легких</article-title><trans-title-group xml:lang="en"><trans-title>The Content of Intercellular Adhesion Molecules in Patients With COVID-19-Associated Lung Disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1704-490X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Караченова</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Karachenova</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Караченова Анастасия Михайловна — ассистент кафедры поликлинической терапии с курсом медицинской реабилитации</p><p>Чита</p></bio><bio xml:lang="en"><p>Karachenova Anastasia Mikhailovna — assistant of the Department of Polyclinic Therapy with a course of medical rehabilitation</p><p>Chita </p></bio><email xlink:type="simple">b_a_m_2010@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-1448-3069</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романова</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanova</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Романова Елена Николаевна — д.м.н., доцент, заведующая кафедрой поликлинической терапии с курсом медицинской реабилитации</p><p>Чита</p></bio><bio xml:lang="en"><p>Romanova Elena Nikolaevna — doctor of Medical Sciences, associate Professor, Head of the Department of Polyclinic Therapy with a course of Medical Rehabilitation</p><p>Chita </p></bio><email xlink:type="simple">elenar-chita@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Читинская государственная медицинская академия» Министерства здравоохранения Российской Федерации, кафедра поликлинической терапии с курсом медицинской реабилитации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy, Department of polyclinic therapy with a course of medical rehabilitation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>26</day><month>05</month><year>2025</year></pub-date><volume>15</volume><issue>3</issue><fpage>187</fpage><lpage>198</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Караченова А.М., Романова Е.Н., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Караченова А.М., Романова Е.Н.</copyright-holder><copyright-holder xml:lang="en">Karachenova A.M., Romanova E.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medarhive.ru/jour/article/view/2004">https://www.medarhive.ru/jour/article/view/2004</self-uri><abstract><p>Цель. Оценить содержание молекул межклеточной адгезии: ICAM-1, ICAM-2, ICAM-3, NCAM, VCAM-1, PECAM-1, E-sel, P-sel, EpCAM, L-sel у пациентов с COVID-19-ассоциированным поражением легких и выявить наличие взаимосвязи между их концентрацией и тяжестью течения процесса. Материалы и методы. В исследование были включены 200 пациентов после перенесенного COVID-19-ассоциированного поражения легких через 1 месяц после выписки из моностационаров г. Читы. Исследуемые были разделены на группы по 50 человек, в зависимости от степени поражения легких по результатам проведения компьютерной томографии: 1-я группа (КТ-1), 2-я группа (КТ-2), 3-я группа (КТ-3), 4-я группа (КТ-4). В группу контроля были включены 56 относительно здоровых лиц, не болевших ранее коронавирусной инфекцией и другими острыми респираторными заболеваниями за последние 3 месяца. Все исследуемые группы были сопоставимы по полу и возрасту. Содержание молекул межклеточной адгезии в сыворотки крови определяли методом иммунохимического анализа. Результаты. В результате проведенного исследования было выявлено повышенное содержание молекул межклеточной адгезии (ММА) (ICAM-1, ICAM-2, ICAM-3, NCAM, VCAM-1, PECAM-1, E-sel, P-sel, EpCAM, L-sel) у исследуемых групп больных с COVID-19-ассоциированным поражением легких в сравнении с группой контроля. Были обнаружены различия между группами пациентов с разным уровнем поражения легких по данным КТ, при исследовании некоторых молекул межклеточной адгезии. Заключение. По итогам проведенной работы выявлено, что после перенесенной коронавирусной инфекции, осложненной поражением легких, в крови наблюдается повышение концентрации молекул межклеточной адгезии — представителей всех исследуемых суперсемейств. Увеличение уровней молекул межклеточной адгезии у исследуемых пациентов отражает наличие эндотелиоза и коррелирует с тяжестью поражения легочной ткани, в том числе и в период реконвалесценции.</p></abstract><trans-abstract xml:lang="en"><p>Objective. To evaluate the content of intercellular adhesion molecules: ICAM-1, ICAM-2, ICAM-3, NCAM, VCAM-1, PECAM-1, E-sel, P-sel, EpCAM, L-sel in patients with COVID-19-associated lung damage and to identify the relationship between their concentration and severity the flow of the process. Materials and methods. The study included 200 patients after suffering COVID-19-associated lung damage 1 month after discharge from Chita monostationals. The subjects were divided into groups of 50 people, depending on the degree of lung damage according to the results of computed tomography: Group 1 (CT-1), median age was 51.5 [50.5; 54.8]; Group 2 (CT-2), median age 57.0 [53.1; 57.0]; group 3 (CT-3), median age 52.5 [51.9; 55.0]; 4th group (CT-4), median 55.0 [53.2; 56.4]. The control group included 56 relatively healthy individuals who had not previously had coronavirus infection and other acute respiratory diseases in the last 3 months, the median age was 55.0 [51.1; 55.0]. All the study groups were comparable in gender and age. The content of intercellular adhesion molecules in blood serum was determined by immunochemical analysis. Results. The study revealed an increased content of intercellular adhesion molecules (MMA) (ICAM-1, ICAM-2, ICAM-3, NCAM, VCAM-1, PECAM-1, E-sel, P-sel, EpCAM, L-sel) in the studied groups of patients with COVID-19-associated lung damage in comparison with the control group. Differences were found between groups of patients with different levels of lung damage according to CT data, when examining some intercellular adhesion molecules. Conclusion. According to the results of the work carried out, it was revealed that after a coronavirus infection complicated by lung damage, an increase in the concentration of intercellular adhesion molecules in the blood is observed — representatives of all the studied superfamilies. An increase in the levels of intercellular adhesion molecules in the studied patients reflects the presence of endotheliosis and correlates with the severity of lung tissue damage, including during the period of convalescence.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>COVID-19-ассоциированное поражение легких</kwd><kwd>молекулы межклеточной адгезии</kwd><kwd>ICAM-1</kwd><kwd>ICAM-2</kwd><kwd>ICAM-3</kwd><kwd>NCAM</kwd><kwd>VCAM-1</kwd><kwd>PECAM-1</kwd><kwd>E-sel</kwd><kwd>P-sel</kwd><kwd>EpCAM</kwd><kwd>L-sel</kwd></kwd-group><kwd-group xml:lang="en"><kwd>COVID-19-associated lung damage</kwd><kwd>intercellular adhesion molecules</kwd><kwd>ICAM-1</kwd><kwd>ICAM-2</kwd><kwd>ICAM-3</kwd><kwd>NCAM</kwd><kwd>VCAM-1</kwd><kwd>PECAM-1</kwd><kwd>E-sel</kwd><kwd>P-sel</kwd><kwd>EpCAM</kwd><kwd>L-sel</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при финансовой поддержке ФГБОУ ВО Читинская государственная медицинская академия Минздрава РФ в рамках утвержденного плана НИР</funding-statement><funding-statement xml:lang="en">The work was carried out with the financial support of the Chita State Medical Academy of the Ministry of Health of the Russian Federation within the framework of the approved research plan</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Москалец О.В. Молекулы клеточной адгезии ICAM-1 и VCAM-1 при инфекционной патологии. Тихоокеанский медицинский журнал. 2018; 2:21-25. doi: 10.17238/PmJ1609-1175.2018.2.21–25.</mixed-citation><mixed-citation xml:lang="en">Moskalets O.V. Molecules of cellular adhesion icam-1 and vcam- 1 in infectious pathology. Pacific Medical Journal. 2018; 2:21-25. doi: 10.17238/PmJ1609-1175.2018.2.21–25. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nat Pernick. CD Markers. 2014 [Electronic resource]. URL: https://www.pathologyoutlines.com/stains.html. (date of the application: 15.10.2024).</mixed-citation><mixed-citation xml:lang="en">Nat Pernick. CD Markers. 2014 [Electronic resource]. URL: https://www.pathologyoutlines.com/stains.html. (date of the application: 15.10.2024).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sands B.E. Inflammatory bowel disease: past, present, and future. J Gastroenterol. 2007;42(1):16-25. doi: 10.1007/s00535-006-1995-7.</mixed-citation><mixed-citation xml:lang="en">Sands B.E. Inflammatory bowel disease: past, present, and future. J Gastroenterol. 2007;42(1):16-25. doi: 10.1007/s00535-006-1995-7.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Петрищева Н.Н., Васина Л.В. Нарушение адгезионной активности как форма эндотелиальной дисфункции. Трансляционная медицина. 2014; (3):5-15. doi.org/10.18705/2311-4495-2014-0-3-5-15.</mixed-citation><mixed-citation xml:lang="en">Petrishchev N.N., Vasina L.V. Disorders of adhesive activity as a form of endothelial dysfunction. Translational Medicine. 2014; (3):5-15. doi. org/10.18705/2311-4495-2014-0-3-5-15. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">National Library of Medicine. 2020. [Electronic resource]. URL: https://medlineplus.gov/genetics/gene/epcam/. (date of the application: 15.10.2024).</mixed-citation><mixed-citation xml:lang="en">National Library of Medicine. 2020. [Electronic resource]. URL: https://medlineplus.gov/genetics/gene/epcam/. (date of the application: 15.10.2024).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров В.А. Алгоритмы статистического анализа данных биомедицинских исследований с помощью пакета программ SPSS (доступным языком). М., Логосфера, 2022; 143 c.</mixed-citation><mixed-citation xml:lang="en">Mudrov V.A. A. Algorithms for statistical analysis of biomedical research data using the SPSS software package (in accessible language). M, Logosphere. 2022; 143 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров В.А. Алгоритмы статистического анализа количественных признаков в биомедицинских исследованиях с помощью пакета программ SPSS. Забайкальский медицинский вестник. 2020. [Электронный ресурс]. URL: https://www.elibrary.ru/download/elibrary_42736765_39471871. (дата обращения: 15.10.2024).</mixed-citation><mixed-citation xml:lang="en">Mudrov V.A. Statistical analysis algorithms of quantitative features in biomedical researchusing the spss software package. Transbaikalian medical bulletin. 2020. [Electronic resource]. URL: https://www.elibrary.ru/download/elibrary_42736765_39471871. (date of the application: 15.10.2024).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Petruzziello-Pellegrini T.N., Moslemi-Naeni M., Marsden P.A. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome. Virulence. 2013; 4(6):556–563. doi: 10.4161/viru.26143.</mixed-citation><mixed-citation xml:lang="en">Petruzziello-Pellegrini T.N., Moslemi-Naeni M., Marsden P.A. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome. Virulence. 2013; 4(6):556–563. doi: 10.4161/viru.26143.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt E.P., Kuiebler W.M., Lee W.L. et al. Adhesion molecules: Master controllers of the circulatory system. Compr. Physiol. 2016; 6(2):945–973. doi: 10.1002/cphy.c150020.</mixed-citation><mixed-citation xml:lang="en">Schmidt E.P., Kuiebler W.M., Lee W.L. et al. Adhesion molecules: Master controllers of the circulatory system. Compr. Physiol. 2016; 6(2):945–973. doi: 10.1002/cphy.c150020.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Черний В.И. Нарушения иммунитета при критических состояниях: особенности диагностики. Газета «Новости медицины и фармации». 2008; 13-14:249-250.</mixed-citation><mixed-citation xml:lang="en">Chernij V.I. Immune disorders in critical conditions: diagnostic features. The newspaper “News of medicine and pharmacy”. 2008; 13-14:249-250. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков В.В., Караулов А.В. «Шторм» растворимых дифференцировочных молекул при COVID-19. Иммунология. 2022; 43(4):458– 467. doi: https://doi.org/10.33029/0206-4952-2022-43-4-458-467.</mixed-citation><mixed-citation xml:lang="en">Novikov V.V., Karaulov A.V. «Storm» of soluble differentiation molecules in COVID-19. Immunologiya. 2022; 43(4):458–467. doi: https://doi.org/10.33029/0206-4952-2022-43-4-458-467. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Романова Е.Н. Пневмонии у больных гриппом A/H1N1/09: клинико-патогенетические закономерности и исходы [диссертация, док. мед. наук]. «Читинская государственная медицинская академия» МЗ РФ. 2014.</mixed-citation><mixed-citation xml:lang="en">Romanova E.N. Pneumonia in patients with influenza A/H1N1/09: clinical and pathogenetic patterns and outcomes [dissertation, Doctor of Medical Sciences]. Сhita State Medical Academy of the Ministry of Health of the Russian Federation. 2014. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Павленко В.В., Амирханова Л.З., Катаганова Г.А. и др. Растворимые молекулы адгезии (ICAM-1, ICAM-2 и L-Селектин) при язвенном колите. Медицинский вестник Северного Кавказа. 2012. [Электронный ресурс]. URL: https://cyberleninka.ru/article/n/rastvorimye-molekuly-adgezii-icam-1-icam-2-i-l-selektin-priyazvennom-kolite (дата обращения: 15.10.2024).</mixed-citation><mixed-citation xml:lang="en">Pavlenko V.V., Amirkhanova L.Z., Kataganova G.A. et al. Soluble adhesion molecules (icam-1, icam-2 and l-selectin) at ulcerative colitis. 2012. [Electronic resource]. URL: https://cyberleninka.ru/article/n/rastvorimye-molekuly-adgezii-icam-1-icam-2-i-l-selektin-pri-yazvennom-kolite. (date of the application: 15.10.2024). [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lyck R, Enzmann G. The physiological roles of ICAM-1 and ICAM-2 in neutrophil migration into tissues. Curr Opin Hematol. 2015; 22(1):53-9. doi: 10.1097/MOH.0000000000000103.</mixed-citation><mixed-citation xml:lang="en">Lyck R, Enzmann G. The physiological roles of ICAM-1 and ICAM-2 in neutrophil migration into tissues. Curr Opin Hematol. 2015; 22(1):53-9. doi: 10.1097/MOH.0000000000000103.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sokolovskaya A, Korneeva E, Zaichenko D et al. Changes in the Surface Expression of Intercellular Adhesion Molecule 3, the Induction of Apoptosis, and the Inhibition of Cell-Cycle Progression of Human MultidrugResistant Jurkat/A4 Cells Exposed to a Random Positioning Machine. Int J Mol Sci. 2020; 28:21(3):855. doi: 10.3390/ijms21030855.</mixed-citation><mixed-citation xml:lang="en">Sokolovskaya A, Korneeva E, Zaichenko D et al. Changes in the Surface Expression of Intercellular Adhesion Molecule 3, the Induction of Apoptosis, and the Inhibition of Cell-Cycle Progression of Human MultidrugResistant Jurkat/A4 Cells Exposed to a Random Positioning Machine. Int J Mol Sci. 2020; 28:21(3):855. doi: 10.3390/ijms21030855.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Petruzziello-Pellegrini T.N., Moslemi-Naeni M., Marsden P.A. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome. Virulence. 2013; 4(6):556–563. doi: 10.4161/viru.26143.</mixed-citation><mixed-citation xml:lang="en">Petruzziello-Pellegrini T.N., Moslemi-Naeni M., Marsden P.A. New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome. Virulence. 2013; 4(6):556–563. doi: 10.4161/viru.26143.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Van Acker HH, Capsomidis A, Smits EL et al. CD56 in the Immune System: More Than a Marker for Cytotoxicity? Front Immunol. 2017; 24(8):892. doi: 10.3389/fimmu.2017.00892.</mixed-citation><mixed-citation xml:lang="en">Van Acker HH, Capsomidis A, Smits EL et al. CD56 in the Immune System: More Than a Marker for Cytotoxicity? Front Immunol. 2017; 24(8):892. doi: 10.3389/fimmu.2017.00892.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kong D.H., Kim Y.K., Kim M.R. et al. Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int J Mol Sci. 2018; 2:19(4):1057. doi: 10.3390/ijms19041057.</mixed-citation><mixed-citation xml:lang="en">Kong D.H., Kim Y.K., Kim M.R. et al. Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int J Mol Sci. 2018; 2:19(4):1057. doi: 10.3390/ijms19041057.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Jones SC, Banks RE, Haidar A et al. Adhesion molecules in inflammatory bowel disease. Gut. 1995; 36(5):724-730. doi: 10.1136/gut.36.5.724.</mixed-citation><mixed-citation xml:lang="en">Jones SC, Banks RE, Haidar A et al. Adhesion molecules in inflammatory bowel disease. Gut. 1995; 36(5):724-730. doi: 10.1136/gut.36.5.724.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Villar J., Muros M., Cabrera-Benítez N.E. et al. Soluble platelet-endothelial cell adhesion molecule-1, a biomarker of ventilator-induced lung injury. Crit Care. 2014; 3:18(2). doi: 10.1186/cc13754.</mixed-citation><mixed-citation xml:lang="en">Villar J., Muros M., Cabrera-Benítez N.E. et al. Soluble platelet-endothelial cell adhesion molecule-1, a biomarker of ventilator-induced lung injury. Crit Care. 2014; 3:18(2). doi: 10.1186/cc13754.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt E.P., Kuiebler W.M., Lee W.L. et al. Adhesion molecules: Master controllers of the circulatory system. Compr. Physiol. 2016; 6(2):945–973. doi: 10.1002/cphy.c150020.</mixed-citation><mixed-citation xml:lang="en">Schmidt E.P., Kuiebler W.M., Lee W.L. et al. Adhesion molecules: Master controllers of the circulatory system. Compr. Physiol. 2016; 6(2):945–973. doi: 10.1002/cphy.c150020.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Калинин Р.Е., Короткова Н.В., Сучков И.А. и др. Селектины и их участие в патогенезе сердечно-сосудистых заболеваний. Казанский мед. ж. 2022; 103(4):617–627. doi: 10.17816/KMJ2022-617.</mixed-citation><mixed-citation xml:lang="en">Kalinin R.E., Korotkova N.V., Suchkov I.A. et al. Selectins and their involvement in the pathogenesis of cardiovascular diseases. Kazan Medical Journal. 2022; 103(4):617–627. doi: 10.17816/KMJ2022-617. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wayne Smith C. Adhesion molecules and receptors. J Allergy Clin Immunol. 2008; 121(2): 375–379. doi: 10.1016/j.jaci.2007.07.030.</mixed-citation><mixed-citation xml:lang="en">Wayne Smith C. Adhesion molecules and receptors. J Allergy Clin Immunol. 2008; 121(2): 375–379. doi: 10.1016/j.jaci.2007.07.030.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Жито А.В., Юсупова А.О., Привалова Е.В. и др. Маркеры эндотелиальной дисфункции: Е-селектин, эндотелин-1 и фактор фон Виллебранда у пациентов с ишемической болезнью сердца, в том числе, в сочетании с сахарным диабетом 2 типа. Рациональная Фармакотерапия в Кардиологии. 2019; 15(6):892-899. doi: 10.20996/1819-6446-2019-15-6-8.</mixed-citation><mixed-citation xml:lang="en">Zhito A.V., Iusupova A.O., Privalova E.V. et al. Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus. Rational Pharmacotherapy in Cardiology 2019; 15(6):892-899. doi: 10.20996/1819-6446-2019-15-6-892-899. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Murohara T., Buerke M., Lefer A. Polymorphonuclear leucocyte-induced vasoconstriction and endothelial dysfunction. Role of selectins. Arterioscler Thromb. 1994; 14:1509-19. doi: 10.1161/01.atv.14.9.1509.</mixed-citation><mixed-citation xml:lang="en">Murohara T., Buerke M., Lefer A. Polymorphonuclear leucocyte-induced vasoconstriction and endothelial dysfunction. Role of selectins. Arterioscler Thromb. 1994; 14:1509-19. doi: 10.1161/01.atv.14.9.1509.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">De Mayer G., Herman A. Vascular endothelial dysfunction. Prog Cardiovasc Dis. 1997; 49:325-342. doi: 10.1016/s0033-0620(97)80031-x.</mixed-citation><mixed-citation xml:lang="en">De Mayer G., Herman A. Vascular endothelial dysfunction. Prog Cardiovasc Dis. 1997; 49:325-342. doi: 10.1016/s0033-0620(97)80031-x.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Goshchynsky V, Migenko B, Riabokon S. Pathophysiological and pathomorphological aspects of relapse of varicose veins after endovascular laser vein coagulation. Wiad Lek. 2020;7 3(11):2468–2475. doi: 10.36740/WLek202011124.</mixed-citation><mixed-citation xml:lang="en">Goshchynsky V, Migenko B, Riabokon S. Pathophysiological and pathomorphological aspects of relapse of varicose veins after endovascular laser vein coagulation. Wiad Lek. 2020;7 3(11):2468–2475. doi: 10.36740/WLek202011124.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Calder P.C., Ahluwalia N., Albers R., et al. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br J Nutr. 2013; 109(Suppl 1): S1e34. doi: 10.1017/S0007114512005119.</mixed-citation><mixed-citation xml:lang="en">Calder P.C., Ahluwalia N., Albers R., et al. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br J Nutr. 2013; 109(Suppl 1): S1e34. doi: 10.1017/S0007114512005119.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003; 170:191-203. doi: 10.1016/s0021-9150(03)00097-2.</mixed-citation><mixed-citation xml:lang="en">Blankenberg S., Barbaux S., Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis. 2003; 170:191-203. doi: 10.1016/s0021-9150(03)00097-2.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Huang RB, Eniola-Adefeso O. Shear stress modulation of IL-1β- induced E-selectin expression in human endothelial cells. PLoS One. 2012; 7(2):31874. doi: 10.1371/journal.pone.0031874.</mixed-citation><mixed-citation xml:lang="en">Huang RB, Eniola-Adefeso O. Shear stress modulation of IL-1β- induced E-selectin expression in human endothelial cells. PLoS One. 2012; 7(2):31874. doi: 10.1371/journal.pone.0031874.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Nishiwaki Y, Yoshida M, Iwaguro H. et al. Endothelial E-selectin potentiates neovascularization via endothelial progenitor cell-dependent and -independent mechanisms. Arterioscler Thromb Vasc Biol. 2007; 27(3):512–518. doi: 10.1161/01.ATV.0000254812.23238.2b.</mixed-citation><mixed-citation xml:lang="en">Nishiwaki Y, Yoshida M, Iwaguro H. et al. Endothelial E-selectin potentiates neovascularization via endothelial progenitor cell-dependent and -independent mechanisms. Arterioscler Thromb Vasc Biol. 2007; 27(3):512–518. doi: 10.1161/01.ATV.0000254812.23238.2b.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Jutila MA, Watts G, Walcheck B et al. Characterization of a functionally important and evolutionarily well-conserved epitope mapped to the short consensus repeats of E-selectin and L-selectin. J Exp Med. 1992; 175(6):1565–1573. doi: 10.1084/jem.175.6.1565.</mixed-citation><mixed-citation xml:lang="en">Jutila MA, Watts G, Walcheck B et al. Characterization of a functionally important and evolutionarily well-conserved epitope mapped to the short consensus repeats of E-selectin and L-selectin. J Exp Med. 1992; 175(6):1565–1573. doi: 10.1084/jem.175.6.1565.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996; 88(9):3259–3287. doi: 10.1182/blood.V88.9.3259.bloodjournal8893259.</mixed-citation><mixed-citation xml:lang="en">Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996; 88(9):3259–3287. doi: 10.1182/blood.V88.9.3259.bloodjournal8893259.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hossain M, Qadri SM, Liu L. Inhibition of nitric оxide synthesis enhances leukocyte rolling and adhesion in human microvasculature. J Inflamm (Lond). 2012; 9:28. doi: 10.1186/1476-9255-9-28.</mixed-citation><mixed-citation xml:lang="en">Hossain M, Qadri SM, Liu L. Inhibition of nitric оxide synthesis enhances leukocyte rolling and adhesion in human microvasculature. J Inflamm (Lond). 2012; 9:28. doi: 10.1186/1476-9255-9-28.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Chaitanya GV, Cromer W, Wells S. et al. Metabolic modulation of cytokine-induced brain endothelial adhesion molecule expression. Microcirculation. 2012; 19(2):155–165. doi: 10.1111/j.1549-8719.2011.00141.x.</mixed-citation><mixed-citation xml:lang="en">Chaitanya GV, Cromer W, Wells S. et al. Metabolic modulation of cytokine-induced brain endothelial adhesion molecule expression. Microcirculation. 2012; 19(2):155–165. doi: 10.1111/j.1549-8719.2011.00141.x.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Collins R.G., Velji R., Guevara N.V. et al. P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2000; 191(1):189–194. doi: 10.1084/jem.191.1.189.</mixed-citation><mixed-citation xml:lang="en">Collins R.G., Velji R., Guevara N.V. et al. P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2000; 191(1):189–194. doi: 10.1084/jem.191.1.189.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Siddiqui K, George TP, Mujammami M, et al. The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study. Front Endocrinol (Lausanne). 2023. doi: 10.3389/fendo.2023.1072288.</mixed-citation><mixed-citation xml:lang="en">Siddiqui K, George TP, Mujammami M, et al. The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study. Front Endocrinol (Lausanne). 2023. doi: 10.3389/fendo.2023.1072288.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Jutila MA, Watts G, Walcheck B, et a l. Characterization of a functionally important and evolutionarily well-conserved epitope mapped to the short consensus repeats of E-selectin and L-selectin. J Exp Med. 1992; 175(6):1565–1573. doi: 10.1084/jem.175.6.1565.</mixed-citation><mixed-citation xml:lang="en">Jutila MA, Watts G, Walcheck B, et a l. Characterization of a functionally important and evolutionarily well-conserved epitope mapped to the short consensus repeats of E-selectin and L-selectin. J Exp Med. 1992; 175(6):1565–1573. doi: 10.1084/jem.175.6.1565.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Белоцкий С.М., Авталион Р.Р. Воспаление. Мобилизация клеток и клинические эффекты. М, БИНОМ. 2008; 240 с.</mixed-citation><mixed-citation xml:lang="en">Belockij S.M., Avtalion R.R. Inflammation. Cell mobilization and clinical effects. M, BINOMIAL. 2008; 240 p. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Потякина К.Е. Ген EPCAM. ГЕНОКАРТА Генетическая энциклопедия. 2020. [Электронный ресурс]. URL: https://www.genokarta.ru/gene/EPCAM. (дата обращения: 24.10.2024).</mixed-citation><mixed-citation xml:lang="en">Potyakina K.E. The EPCAM gene. The GENOCARD is a genetic encyclopedia. 2020. [Electronic resource]. URL: https://www.genokarta.ru/gene/EPCAM. (date of the application: 24.10.2024). [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Smith-Norowitz T.A., Loeffl er J., Norowitz Y.M. et al. Intracellular adhesion molecule-1 (ICAM-1) levels in convalescent COVID-19 serum: a case report. Ann. Clin. Lab. Sci. 2021 [Electronic resource]. URL: https://pubmed.ncbi.nlm.nih.gov/34686518/. (date of the application: 24.10.2024).</mixed-citation><mixed-citation xml:lang="en">Smith-Norowitz T.A., Loeffl er J., Norowitz Y.M. et al. Intracellular adhesion molecule-1 (ICAM-1) levels in convalescent COVID-19 serum: a case report. Ann. Clin. Lab. Sci. 2021 [Electronic resource]. URL: https://pubmed.ncbi.nlm.nih.gov/34686518/. (date of the application: 24.10.2024).</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Tong M., Jiang Y., Xia D. et al. Elevated expression of serum endothelial cell adhesion molecules in COVID-19 patients. J. Infect. Dis. 2020; 222:894–8. doi: https://doi.org/10.1093/infdis/jiaa349.</mixed-citation><mixed-citation xml:lang="en">Tong M., Jiang Y., Xia D. et al. Elevated expression of serum endothelial cell adhesion molecules in COVID-19 patients. J. Infect. Dis. 2020; 222:894–8. doi: https://doi.org/10.1093/infdis/jiaa349.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Kaur S., Hussain S., Kolhe K. et al. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis. JHEP Rep. 2021; 3(4):100303. doi: https://doi.org/10.1016/j.jhepr.2021.</mixed-citation><mixed-citation xml:lang="en">Kaur S., Hussain S., Kolhe K. et al. Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis. JHEP Rep. 2021; 3(4):100303. doi: https://doi.org/10.1016/j.jhepr.2021.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
